



Aromatase-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/Aromatase.html AromataseAromatase (estrogen synthetase, CYP19) is a unique cytochrome P450 that catalyzes the removal of the 19-methyl group andaromatization of the A-ring of androgens for the synthesis of estrogens. All human estrogens are synthesized via this
2、 enzymaticaromatization pathway. Aromatase is most widely known for its roles in reproduction and reproductive system diseases, and as atarget for inhibitor therapy in estrogen-sensitive diseases including cancer, endometriosis, and leiomyoma.The selective inhibition of estrogen production by aromat
3、ase inhibitors is an efficient strategy for breast cancer treatment. Thesecompounds are classified as irreversible inhibitors of aromatase (type I), and comprise steroidal compounds. Reversible inhibitors ofaromatase, which comprises non-steroidal compounds are type II aromatase inhibitors. Second a
4、nd third generation aromataseinhibitors are considerably more potent and more specific in their ability to inhibit aromatase, as compared with first generationcompounds (aminoglutethimide).www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Aromatase.html Aromatase HYPERLINK https:/www.MedChemE/Tar
5、gets/Aromatase.html HYPERLINK https:/www.MedChemE/Targets/Aromatase.html Inhibitors HYPERLINK https:/www.MedChemE/alpha-naphthoflavone.html Alpha-NaphthoflavoneCat. No.: HY-125833 HYPERLINK https:/www.MedChemE/Anastrozole.html Anastrozole(ZD1033) Cat. No.: HY-14274Alpha-Naphthoflavone is a synthetic
6、 flavonoid,acts as a potent and competitive aromataseinhibitor with an IC50 and a Ki of 0.5 and 0.2 M,respectively.Anastrozole is a potent, highly selectivearomatase inhibitor, which inhibits humanplacental aromatase with an IC of 15 nM.50Purity: 98.02%Clinical Data: No Development ReportedSize: 10
7、mM 1 mL, 5 mg, 10 mg, 20 mgPurity: 99.99%Clinical Data: LaunchedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/anastrozole-d12.html Anastrozole-d12(ZD1033-d12) Cat. No.: HY-14274S HYPERLINK https:/www.MedChemE/anastrozole-d3-dimer-impurity.html Anastrozole-d3 HYPERLINK https:/w
8、ww.MedChemE/anastrozole-d3-dimer-impurity.html HYPERLINK https:/www.MedChemE/anastrozole-d3-dimer-impurity.html Dimer HYPERLINK https:/www.MedChemE/anastrozole-d3-dimer-impurity.html HYPERLINK https:/www.MedChemE/anastrozole-d3-dimer-impurity.html ImpurityCat. No.: HY-14274S1Anastrozole-d12 (ZD1033-
9、d12) is the deuteriumlabeled Anastrozole. Anastrozole is a potent,highly selective aromatase inhibitor, whichinhibits human placental aromatase with an IC of5015 nM.Anastrozole-d3 Dimer Impurity is the deuteriumlabeled Anastrozole. Anastrozole is a potent,highly selective aromatase inhibitor, whichi
10、nhibits human placental aromatase with an IC of5015 nM.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 10 mg HYPERLINK https:/www.MedChemE/androsta-1-4-6-triene-3-17-dione.html Androsta-1,4,6-triene-3,17-dione HYPERLINK https:/
11、www.MedChemE/androsta-1-4-6-triene-3-17-dione.html HYPERLINK https:/www.MedChemE/Endoxifen.html EndoxifenCat. No.: HY-136092 Cat. No.: HY-18719EAndrosta-1,4,6-triene-3,17-dione is a lipophilicand specific aromatase inhibitor with a K ofi0.18 M. Androsta-1,4,6-triene-3,17-dione inhibitsestrogen biosy
12、nthesis and shows antifertilityeffects. Androsta-1,4,6-triene-3,17-dione inducesimpairment of spatial memory.Endoxifen is a key active metabolite of tamoxifen(TAM) with higher affinity and specificity toestrogen receptor that also inhibits aromataseactivity. Endoxifen has the potential for breastcan
13、cer study.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Endoxifen-hydrochloride.html Endoxifen HYPERLINK https:/www.MedChemE/Endoxifen-hydrochloride.html HYPERLINK https:/www.MedChemE/E
14、ndoxifen-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/Endoxifen-hydrochloride.html HYPERLINK https:/www.MedChemE/endoxifen-d5-1-1-e-z-mixture.html Endoxifen-d5Cat. No.: HY-18719B Cat. No.: HY-18719ESEndoxifen hydrochloride is a key active metaboliteof Tamoxifen (TAM) with higher af
15、finity andspecificity to estrogen receptor that alsoinhibits aromatase activity. Endoxifenhydrochloride has the potential for breast cancerstudy.Endoxifen-d5 is the deuterium labeled Endoxifen.Endoxifen is a key active metabolite of tamoxifen(TAM) with higher affinity and specificity toestrogen rece
16、ptor that also inhibits aromataseactivity. Endoxifen has the potential for breastcancer study.Purity: 98.20%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mg HYPERLINK https:/www.MedChemE/eriodictyol-chalcon
17、e.html Eriodictyol HYPERLINK https:/www.MedChemE/eriodictyol-chalcone.html HYPERLINK https:/www.MedChemE/eriodictyol-chalcone.html chalcone HYPERLINK https:/www.MedChemE/eriodictyol-chalcone.html HYPERLINK https:/www.MedChemE/Exemestane.html ExemestaneCat. No.: HY-N9551(FCE 24304; EXE) Cat. No.: HY-
18、13632Eriodictyol chalcone possesses bothanti-aromatase and an anti-17-HSD activity.Exemestane (FCE 24304) is a selective,irreversible and orally active steroidalaromatase inhibitor with IC s of 30 nM and 4050nM for human placental and rat ovarianaromatase, respectively. Exemestane can be usedfor hor
19、mone-dependent breast cancer research.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 99.95%Clinical Data: LaunchedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/exemestane-13c3.html Exem
20、estane-13C3Cat. No.: HY-13632S1 HYPERLINK https:/www.MedChemE/exemestane-d2.html Exemestane-D2(FCE 24304-D2; EXE-D2) Cat. No.: HY-13632SExemestane-13C3 is the 13C-labeled Exemestane.Exemestane (FCE 24304) is a selective,irreversible and orally active steroidalaromatase inhibitor with IC s of 30 nM a
21、nd 4050nM for human placental and rat ovarianaromatase, respectively.Exemestane-D2 (FCE 24304-D2) is the deuteriumlabeled Exemestane. Exemestane (FCE 24304) is aselective, irreversible and orally activesteroidal aromatase inhibitor with IC s of 3050nM and 40 nM for human placental and ratovarian aro
22、matase, respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/exemestane-d3.html Exemestane-d3(FCE 24304-d3; EXE-d3) Cat. No.: HY-13632S2 HYPERLINK https:/www.MedChemE/Fadro
23、zole.html Fadrozole(CGS 16949A free base; (Rac)-FAD286) Cat. No.: HY-14247AExemestane-d3 (FCE 24304-d3) is the deuteriumlabeled Exemestane. Exemestane (FCE 24304) is aselective, irreversible and orally activesteroidal aromatase inhibitor with IC s of 3050nM and 40 nM for human placental and ratovari
24、an aromatase, respectively.Fadrozole (CGS 16949A free base) is a potent,selective and nonsteroidal inhibitor ofaromatase with an IC of 6.4 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.69%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HY
25、PERLINK https:/www.MedChemE/Fadrozole_hydrochloride.html Fadrozole HYPERLINK https:/www.MedChemE/Fadrozole_hydrochloride.html HYPERLINK https:/www.MedChemE/Fadrozole_hydrochloride.html hydrochloride(CGS 16949A; (Rac)-FAD286 hydrochloride) Cat. No.: HY-14247 HYPERLINK https:/www.MedChemE/flavanone.ht
26、ml FlavanoneCat. No.: HY-N7128Fadrozole hydrochloride (CGS 16949A) is a potent,selective and nonsteroidal inhibitor ofaromatase with an IC of 6.4 nM.50Flavanone is a naturally occurring flavone.Flavanone has inhibitory activity for humanestrogen synthetase (aromatase).Purity: 99.22%Clinical Data: La
27、unchedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.94%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 100 mg HYPERLINK https:/www.MedChemE/isolimonexic-acid.html Isolimonexic HYPERLINK https:/www.MedChemE/isolimonexic-acid.html HYPERLINK https:/www.MedChemE/isolimonexic-acid
28、.html acid HYPERLINK https:/www.MedChemE/isolimonexic-acid.html HYPERLINK https:/www.MedChemE/Letrozole.html LetrozoleCat. No.: HY-N8405(CGS 20267) Cat. No.: HY-14248Isolimonexic acid is a limonoid isolated fromlemon (Citrus lemon L. Burm) seed, hasanti-cancer and anti-aromatase (IC =25.6050M) prope
29、rties.Letrozole (CGS 20267) is a potent, selective,reversible and orally active non-steroidalinhibitor of aromatase, with an IC of 11.550nM. Letrozole selective inhibits estrogenbiosynthesis, and can be used for the research ofbreast cancer.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg
30、, 10 mg, 25 mgPurity: 99.92%Clinical Data: LaunchedSize: 10 mM 1 mL, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/letrozole-d4.html Letrozole-d4 HYPERLINK https:/www.MedChemE/letrozole-d4.html HYPERLINK https:/www.MedChemE/oleuropein.html OleuropeinCat. No.: HY-14248S Cat. No.: HY-N0292Letro
31、zole-d4 (CGS 20267-d4) is the deuteriumlabeled Letrozole. Letrozole (CGS 20267) is apotent, selective, reversible and orally activenon-steroidal inhibitor of aromatase, with anIC of 11.5 nM.50Oleuropein, found in olive leaves and oil, exertsantioxidant, anti-inflammatory andanti-atherogenic effects
32、through direct inhibitionof PPAR transcriptional activity.Purity: 98%Clinical Data:Size: 1 mg, 10 mgPurity: 98.54%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/Org30958.html Org30958 HYPERLINK https:/www.MedChemE/Org30958.html HYPERLINK https:/www.MedChemE/syn20028567.html SYN20028567Cat. No.: HY-U00176 Cat. No.: HY-146688Org30958 is
溫馨提示
- 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 電平顯示器行業(yè)深度研究分析報(bào)告(2024-2030版)
- 2025年中國(guó)多功能電動(dòng)護(hù)理床行業(yè)市場(chǎng)發(fā)展現(xiàn)狀及投資規(guī)劃建議報(bào)告
- 水利法人驗(yàn)收申請(qǐng)報(bào)告
- 中國(guó)蠶豆罐頭行業(yè)市場(chǎng)占有率及投資前景預(yù)測(cè)分析報(bào)告
- 水質(zhì)檢測(cè)之TDS筆(溶解性總固體)可行性分析報(bào)告
- 2025年中國(guó)CVT無(wú)級(jí)變速箱行業(yè)發(fā)展監(jiān)測(cè)及投資戰(zhàn)略研究報(bào)告
- 2024年中國(guó)煙嘧磺隆行業(yè)市場(chǎng)調(diào)查報(bào)告
- 銷售部安全生產(chǎn)責(zé)任制考核表
- 加油站安全生產(chǎn)方針
- 建筑工程項(xiàng)目安全管理制度
- CJJT259-2016 城鎮(zhèn)燃?xì)庾詣?dòng)化系統(tǒng)技術(shù)規(guī)范
- 病案首頁(yè)填寫及質(zhì)控要求
- 18 設(shè)計(jì)緊急避難路線圖(教案)人美版(北京)(2012)美術(shù)三年級(jí)下冊(cè)
- 園林綠化移樹合同
- 排球大單元計(jì)劃教學(xué)設(shè)計(jì)-高一上學(xué)期體育與健康人教版
- 企業(yè)員工健康促進(jìn)計(jì)劃的設(shè)計(jì)與實(shí)施
- 玻璃粉燒工藝
- 云計(jì)算和邊緣計(jì)算在工業(yè)互聯(lián)網(wǎng)中的融合
- 普通高中物理課程標(biāo)準(zhǔn)解讀
- 成人失禁相關(guān)性皮炎的預(yù)防與護(hù)理-護(hù)理團(tuán)標(biāo)
- 臨時(shí)用電線路的接地與絕緣
評(píng)論
0/150
提交評(píng)論